By expenditures
| Name | Title | Type |
|---|---|---|
| Mary Ann Mahon Huels | President & Ceo | Auditee |
| Anthony Stec | VP OF FINANCE | Auditee |
| Ashley Barsema | Signing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 371657 | 2024 | 2025-10-31 | CLIFTONLARSONALLEN LLP | $3.00M |
| 328459 | 2023 | 2024-11-14 | Cliftonlarsonallen LLP | $3.39M |
| 49124 | 2022 | 2023-08-01 | Cliftonlarsonallen LLP | $3.99M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 371657 | 2024 | 2025-10-31 | 1161722 | 2024-006 | Material Weakness | Yes | AB |
| 371657 | 2024 | 2025-10-31 | 1161721 | 2024-006 | Material Weakness | Yes | AB |
| 371657 | 2024 | 2025-10-31 | 1161720 | 2024-006 | Material Weakness | Yes | AB |
| 371657 | 2024 | 2025-10-31 | 1161719 | 2024-006 | Material Weakness | Yes | AB |
| 371657 | 2024 | 2025-10-31 | 1161718 | 2024-005 | Material Weakness | Yes | C |
| 371657 | 2024 | 2025-10-31 | 1161717 | 2024-005 | Material Weakness | Yes | C |
| 371657 | 2024 | 2025-10-31 | 1161716 | 2024-005 | Material Weakness | Yes | C |
| 371657 | 2024 | 2025-10-31 | 1161715 | 2024-005 | Material Weakness | Yes | C |
| 371657 | 2024 | 2025-10-31 | 1161714 | 2024-004 | Material Weakness | Yes | ABC |
| 371657 | 2024 | 2025-10-31 | 1161713 | 2024-004 | Material Weakness | Yes | ABC |
| 371657 | 2024 | 2025-10-31 | 1161712 | 2024-004 | Material Weakness | Yes | ABC |
| 371657 | 2024 | 2025-10-31 | 1161711 | 2024-004 | Material Weakness | Yes | ABC |
| 328459 | 2023 | 2024-11-14 | 1084423 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 1084422 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 1084421 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 1084420 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 1084419 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 507981 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 507980 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 507979 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 507978 | 2023-003 | Significant Deficiency | - | CL |
| 328459 | 2023 | 2024-11-14 | 507977 | 2023-003 | Significant Deficiency | - | CL |